Abcam Ltd.

Company Overview

Founded in 1998, Abcam is a life science research company. It supplies the global life science community with antibodies, reagents, and kits to help accelerate the next breakthrough in drug discovery, diagnostics, and basic research. Abcam offers over 110,000 products to research protein targets – across antibodies, proteins, lysates, biochemicals, kits and assays, in over 130 countries. 

Abcam primarily deals in antibodies intended for basic research in academic pharma and biotech laboratories. Abcam is a manufacturer and distributor of research-grade primary and secondary antibodies, biochemicals, proteins, peptides, lysates, immunoassays, and other associated kits. The company’s major research areas are cancer, cardiovascular, cell biology, developmental biology, epigenetics & nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction and stem cells. The first notable success for the company was Chromatin antibodies, loading control antibodies and GFP antibodies. Lately Abcam has broadened its offering as a development and a supply partner in the diagnostics market. It provides in vitro diagnostic (IVD) antibodies, which are primarily used in a clinical setting to help diagnose a particular disease or condition.

Abcam also has custom products and licensing diagnostics teams, which are responsible for the research, manufacture, customized development and commercial licensing of rabbit monoclonal antibodies and phage-derived recombinant antibodies for diagnostic use.

Company's Business Segments

• Products : Abcam primarily generates its revenue from various bioproducts under several antigens such as Primary antibodies, Secondary antibodies, Biochemicals, Isotype controls, Flow cytometry multi-color selector, Kits, Loading controls, Others.